2Mitsunhori H. A randomized phade Ⅰ study of (2"R)-4-o-tetrahydropy-ranyladriamycin and adriamycill in combination with vith vincristine and ACNU for small cell lung cancer-THPADM. VCR. ACNU VS ADM, VCR,ACNU[J]. Jpn J Cancer Chemother,1989,16(9):3134.
3Setsuko K. Rapid uptake by cultured tumor cells and intracellular behavior of 4'-O-tetrahydropyranyl-adriamycin[J].J Antibiot, 1983,36 : 312.
4Nakagawa S, Kojima M, Takada H, et al. Short-duration bladder instillation therapy with pirarubicin for superficial bladder tumor based on pharmacodynamic study[J]. Gan To Kagaku Ryoho,1992,19(11):1873--1877.
6Salvador-Bayarri J,Rodriguez-Villarnil L,Imperatore V,et al.Bladder neoplasms after nephroureterectomy:does the surgery of the lower ureter,transurethral resection or open surgery,influence the evolution? Eur Urol,2002,41:30-33.
7Matsui Y,Utsunomiya N,Ichioka K,et al.Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract.Urology,2005,65:279-283.
8Li XB,Xing NZ,Wang Y,et al.Transitional cell carcinoma in renal transplant recipients:a single center experience.Int J Urol,2008,15:53-57.
9Zigeuner RE,Hutterer G,Chromecki T,et al.Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location.BJU Int,2006,98:1181-1186.
10Chou EC,Lin AT,Chen KK,et al.Superficial transitional cell carcinoma of the ureteral orifice:higher risk of developing subsequent upper urinary tract tumors.Int J Urol,2006,13:682-685.
